CINECA IRIS Institutional Research Information System

FIORAVANTI, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.168
AS - Asia 1.255
EU - Europa 1.247
SA - Sud America 148
AF - Africa 62
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 6.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.085
SG - Singapore 433
CN - Cina 328
IT - Italia 307
DE - Germania 278
HK - Hong Kong 194
SE - Svezia 170
BR - Brasile 125
VN - Vietnam 120
GB - Regno Unito 93
BG - Bulgaria 87
FR - Francia 83
CA - Canada 66
TR - Turchia 61
FI - Finlandia 52
AT - Austria 50
RU - Federazione Russa 42
IN - India 33
JP - Giappone 29
CI - Costa d'Avorio 25
UA - Ucraina 21
BE - Belgio 18
PL - Polonia 11
BD - Bangladesh 10
NL - Olanda 10
SA - Arabia Saudita 9
MX - Messico 8
NG - Nigeria 8
AR - Argentina 7
EC - Ecuador 7
KR - Corea 7
MA - Marocco 7
ZA - Sudafrica 7
ID - Indonesia 6
SN - Senegal 6
CO - Colombia 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
AU - Australia 4
IQ - Iraq 4
LT - Lituania 4
PK - Pakistan 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JO - Giordania 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
ES - Italia 2
KH - Cambogia 2
LB - Libano 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A1 - Anonimo 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IE - Irlanda 1
IL - Israele 1
MD - Moldavia 1
MY - Malesia 1
PE - Perù 1
SO - Somalia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 6.887
Salva come PNG Salva come JPEG
Città #
Woodbridge 425
Ann Arbor 408
Ashburn 396
Fairfield 384
Houston 321
Singapore 228
Chandler 222
Hong Kong 192
Dallas 183
Seattle 182
Santa Clara 180
Wilmington 170
San Jose 169
Cambridge 138
Serra 132
Sofia 87
Shanghai 80
Beijing 78
New York 66
Ottawa 48
Boardman 45
Vienna 45
Los Angeles 42
Dong Ket 39
Des Moines 36
Izmir 36
Princeton 36
Lauterbourg 35
Medford 35
Council Bluffs 34
Lawrence 34
Dearborn 26
Falls Church 26
Abidjan 25
Frankfurt am Main 25
Tokyo 25
Columbus 23
The Dalles 23
Ho Chi Minh City 22
London 21
Munich 21
Rho 19
Boulder 18
Brussels 18
Istanbul 18
Jacksonville 18
Nanjing 18
Hanoi 17
San Diego 17
Buffalo 16
Florence 15
Nürnberg 15
Redondo Beach 14
Milan 13
São Paulo 13
Turku 13
Bremen 12
Fuzhou 12
Pune 12
Nanchang 11
Seacroft 11
Düsseldorf 9
Pisa 9
Shenyang 9
Lagos 8
Ogden 8
Redwood City 8
Marseille 7
San Francisco 7
Dakar 6
Helsinki 6
Lancaster 6
Montreal 6
Seoul 6
Atlanta 5
Changsha 5
Kunming 5
Norwalk 5
Phoenix 5
Toronto 5
Warsaw 5
Boston 4
Da Nang 4
Indiana 4
Quito 4
Riyadh 4
Stockholm 4
Wroclaw 4
Amman 3
Auburn Hills 3
Bexley 3
Copenhagen 3
Denver 3
Groningen 3
Hefei 3
Jeddah 3
Jiaxing 3
Johannesburg 3
New Delhi 3
Nuremberg 3
Totale 5.237
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 407
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. 298
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 267
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 255
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 252
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 249
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 247
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 243
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 238
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 226
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients 213
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 209
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. 205
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 203
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. 201
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 194
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: evaluation of the effects of switched schedules and related pharmacodynamics 192
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 188
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells 171
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients 168
Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis. 166
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists 164
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. 161
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer 160
Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer 154
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells 152
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer 148
Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions 147
Derivati a nucleo pirazolo[3,4-d]pirimidinico quali inibitori di proteine tirosina chinasi 146
The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells 144
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1 144
A new biometric tool for three-dimensional subcutaneous tumor scanning in mice. 140
Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity. 122
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients 109
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. 109
null 101
null 89
Totale 6.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 51 26 64
2021/2022473 10 41 20 14 76 65 16 21 25 26 22 137
2022/2023652 85 99 60 74 66 89 3 37 105 2 29 3
2023/2024244 21 18 27 5 26 64 9 20 5 6 14 29
2024/20251.173 3 44 5 90 138 142 65 50 150 147 110 229
2025/20261.279 105 127 211 111 147 108 227 60 92 91 0 0
Totale 6.982